We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Public Assessment Report of review of valproate safety data and expert advice on management of risks.
A report covering adverse reactions to approved COVID-19 vaccines
Update on publication status The Commission on Human Medicine (CHM) has…
Update on publication frequency The weekly summary of Yellow Card…
Public Assessment Report on our review of epidemiological data for cardiovascular safety.
1. Plain Language Summary The Medicines and Healthcare products Regulatory…
This PAR covers the assessment of the proposal to make Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets available through general retail outlets.
Public Assessment Report of our review of the use of chloramphenicol eye drops containing borax and boric acid buffers in children under 2 years.
Public Assessment Report on our review of the risks of using haloperidol for the acute treatment of delirium in elderly patients.
This report provides a combined summary of the conclusions and recommendations of the Commission on Human Medicines’ Adrenaline Auto-injector Expert Working Group to support the effective and safe use of Adrenaline Auto-inje…
Public Assessment Report (PAR) reviewing available safety data for topical steroid withdrawal reactions, which have been associated with topical corticosteroids.
The Commission on Human Medicines (CHM) has reviewed the available safety data for the use of the macrolide antibiotics erythromycin, clarithromycin and azithromycin during pregnancy.
The MHRA has developed, and now has in place, a four-stranded approach to vigilance, which is summarised in this report.
The Commission on Human Medicines has reviewed the available safety data for epilepsy medicines during pregnancy.
Public Assessment Report (PAR) discussing new risk minimisation measures which are being put into place for certain over-the-counter (OTC) stimulant laxatives.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).